Suppr超能文献

G 蛋白偶联胆汁酸受体 1 降低了杂交石斑鱼的肝免疫反应,并抑制了 NFκB、PI3K/AKT 和 PKC/P38 MAPK 信号通路。

G protein-coupled bile acid receptor 1 reduced hepatic immune response and inhibited NFκB, PI3K/AKT, and PKC/P38 MAPK signaling pathway in hybrid grouper.

机构信息

Laboratory of Aquatic Animal Nutrition and Feed, Fisheries College, Guangdong Ocean University, Zhanjiang, China.

Guangxi Key Laboratory of Marine Environmental Science, Guangxi Academy of Marine Sciences, Guangxi Academy of Sciences, Nanning, China.

出版信息

J Anim Sci. 2023 Jan 3;101. doi: 10.1093/jas/skad307.

Abstract

The mammalian G protein-coupled bile acid receptor 1 (TGR5) is involved in the inflammatory response. However, the functions of TGR5 in the immune response of fish remain unclear. In this study, the full-length sequence of tgr5 from hybrid grouper (Epinephelus fuscoguttatus ♀ × E. lanceolatus ♂) was cloned, and the function of TGR5 in the immune response was explored. The results showed that the ORF of tgr5 gene in hybrid grouper was 1029 bp and encoded 342 amino acids. Activation of TGR5 by INT-777 significantly decreased the activities and mRNA expression of TNFα and IL1β, whereas inhibition of TGR5 by SBI-115 showed the opposite effect. SBI-115 treatment significantly increased the expression of phosphorylated inhibitor κB α (p-IKBα) protein. After the INT-777 treatment, the concentration of protein kinase C (PKC) and expression of the p38 mitogen-activated protein kinases (p38a), p38b and p38c, were significantly decreased in vivo. INT-777 agonist significantly decreased the expression of phosphorylated phosphoinositide 3-kinase (p-PI3K) protein and the ratio of phosphorylated and nonphosphorylated serine/threonine-protein kinase (p-AKT/AKT). In conclusion, activation of hepatic TGR5 inhibited the PKC/P38 MAPK, PI3K/AKT, NFκB signaling pathway and improved hepatic immune responses of hybrid grouper in vivo and in vitro.

摘要

哺乳动物 G 蛋白偶联胆汁酸受体 1(TGR5)参与炎症反应。然而,TGR5 在鱼类免疫反应中的功能尚不清楚。在本研究中,我们克隆了杂交石斑鱼(♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀♀

相似文献

本文引用的文献

8
Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy.胆汁酸受体 FXR 和 TGR5 在脂肪性肝病及其治疗中的作用。
Am J Physiol Gastrointest Liver Physiol. 2020 Mar 1;318(3):G554-G573. doi: 10.1152/ajpgi.00223.2019. Epub 2020 Jan 27.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验